{"protocolSection":{"identificationModule":{"nctId":"NCT05683379","orgStudyIdInfo":{"id":"RGX-202-0101"},"organization":{"fullName":"REGENXBIO Inc.","class":"INDUSTRY"},"briefTitle":"AFFINITY BEYOND: Anti-AAV8 Antibody Assessment Study of Males With DMD","officialTitle":"Anti-AAV8 Antibody Assessment Study of Males With Duchenne Muscular Dystrophy Aged 0 to <25 Years"},"statusModule":{"statusVerifiedDate":"2025-11","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2022-12-20","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2026-09","type":"ESTIMATED"},"completionDateStruct":{"date":"2026-09","type":"ESTIMATED"},"studyFirstSubmitDate":"2023-01-04","studyFirstSubmitQcDate":"2023-01-12","studyFirstPostDateStruct":{"date":"2023-01-13","type":"ACTUAL"},"lastUpdateSubmitDate":"2025-11-20","lastUpdatePostDateStruct":{"date":"2025-11-25","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"REGENXBIO Inc.","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":true,"isUnapprovedDevice":true},"descriptionModule":{"briefSummary":"This is an observational screening study to evaluate the prevalence of anti-adeno-associated serotype 8 (AAV8) antibodies in participants with Duchenne muscular dystrophy (DMD).","detailedDescription":"This is an observational screening study to evaluate the prevalence of anti-adeno-associated serotype 8 (AAV8) antibodies in participants with Duchenne muscular dystrophy (DMD). Information collected in this study may be used to identify potential participants for DMD investigational gene therapy clinical trials.\n\nThis study consists of:\n\n* A phone/video interview or at an in-clinic visit to provide e-consent and medical history\n* A single home health visit or subsequent in-clinic visit to collect blood sample for antibody testing\n* A phone/video call for communication of AAV8 antibody test results"},"conditionsModule":{"conditions":["Duchenne Muscular Dystrophy"],"keywords":["DMD","Duchenne Muscular Dystrophy","Duchenne"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":false,"designInfo":{"observationalModel":"COHORT","timePerspective":"PROSPECTIVE"},"enrollmentInfo":{"count":200,"type":"ESTIMATED"}},"armsInterventionsModule":{"interventions":[{"type":"DIAGNOSTIC_TEST","name":"AAV8 DetectCDx","description":"An in vitro diagnostic assay to detect antibodies to AAV8 in human serum specimens."}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Prevalence of anti-AAV8 antibodies in patients with DMD","description":"* To evaluate the prevalence of AAV8 antibodies in patients with DMD\n* To identify participants who may be eligible for investigational gene therapy clinical trials in males with DMD","timeFrame":"90 days"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Males at least 0 to \\<25 years of age\n* Diagnosis of DMD\n* Provision of signed and dated informed consent form (ICF) and assent as required per local regulations or requirements\n\nExclusion Criteria:\n\n* Prior participation in a gene therapy trial OR recipient of a gene therapy drug\n* Other inclusion/exclusion criteria apply","healthyVolunteers":false,"sex":"MALE","genderBased":true,"minimumAge":"0 Years","maximumAge":"25 Years","stdAges":["CHILD","ADULT"],"studyPopulation":"Primary care clinic, Musculoskeletal care, Neuromusculoskeletal care","samplingMethod":"PROBABILITY_SAMPLE"},"contactsLocationsModule":{"centralContacts":[{"name":"Patient Advocacy","role":"CONTACT","phone":"(833) 711-0349","email":"Duchenne@regenxbio.com"}],"locations":[{"facility":"Rare Disease Research","status":"RECRUITING","city":"Atlanta","state":"Georgia","zip":"30329","country":"United States","contacts":[{"name":"Lily Goggans","role":"CONTACT","phone":"470-600-9134","email":"lily.goggans@rarediseaseresearch.com"},{"name":"Maureen Ikpeoha","role":"CONTACT","phone":"470-666-1884","email":"maureen.ikpeoha@rarediseaseresearch.com"},{"name":"Han Phan, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":33.749,"lon":-84.38798}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2026-02-25"},"conditionBrowseModule":{"meshes":[{"id":"D020388","term":"Muscular Dystrophy, Duchenne"}],"ancestors":[{"id":"D009136","term":"Muscular Dystrophies"},{"id":"D020966","term":"Muscular Disorders, Atrophic"},{"id":"D009135","term":"Muscular Diseases"},{"id":"D009140","term":"Musculoskeletal Diseases"},{"id":"D009468","term":"Neuromuscular Diseases"},{"id":"D009422","term":"Nervous System Diseases"},{"id":"D040181","term":"Genetic Diseases, X-Linked"},{"id":"D030342","term":"Genetic Diseases, Inborn"},{"id":"D009358","term":"Congenital, Hereditary, and Neonatal Diseases and Abnormalities"}]}},"hasResults":false}